BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33660275)

  • 1. A 3' tRNA-derived fragment produced by tRNA
    Katsaraki K; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Eur J Haematol; 2021 Jun; 106(6):821-830. PubMed ID: 33660275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
    Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay.
    Katsaraki K; Artemaki PI; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Leuk Res; 2019 Dec; 87():106234. PubMed ID: 31669784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
    Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
    Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological behavior of tRNA-derived fragment tRF-Leu-AAG in pancreatic cancer cells.
    Sui S; Wang Z; Cui X; Jin L; Zhu C
    Bioengineered; 2022 Apr; 13(4):10617-10628. PubMed ID: 35442152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia.
    Veneziano D; Tomasello L; Balatti V; Palamarchuk A; Rassenti LZ; Kipps TJ; Pekarsky Y; Croce CM
    Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24252-24258. PubMed ID: 31723042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal tRF-Leu-AAG-001 derived from mast cell as a potential non-invasive diagnostic biomarker for endometriosis.
    Li Y; Cui S; Xu Z; Zhang Y; Wu T; Zhang J; Chen Y
    BMC Womens Health; 2022 Jun; 22(1):253. PubMed ID: 35752827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
    Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
    Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia.
    Kontos CK; Papageorgiou SG; Diamantopoulos MA; Scorilas A; Bazani E; Vasilatou D; Gkontopoulos K; Glezou E; Stavroulaki G; Dimitriadis G; Pappa V
    Leuk Res; 2017 Feb; 53():65-73. PubMed ID: 28038356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.
    Ricca I; Rocci A; Drandi D; Francese R; Compagno M; Lobetti Bodoni C; De Marco F; Astolfi M; Monitillo L; Vallet S; Calvi R; Ficara F; Omedè P; Rosato R; Gallamini A; Marinone C; Bergui L; Boccadoro M; Tarella C; Ladetto M
    Leukemia; 2007 Apr; 21(4):697-705. PubMed ID: 17301820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
    Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
    Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients.
    Abramenko I; Bilous N; Chumak A; Kryachok I; Fedorenko Z; Martina Z; Dyagil I
    Leuk Res; 2021 Nov; 110():106686. PubMed ID: 34492598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
    Adamopoulos PG; Kontos CK; Papageorgiou SG; Pappa V; Scorilas A
    Clin Biochem; 2015 Sep; 48(13-14):849-54. PubMed ID: 25891023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.
    Zou ZJ; Fan L; Wang L; Zhang R; Zhang LN; Yang S; Li JY; Xu W
    Cancer Biomark; 2012; 12(4):169-76. PubMed ID: 23568007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
    Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
    Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
    Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A
    Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
    Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
    Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia.
    Zhu DX; Fan L; Lu RN; Fang C; Shen WY; Zou ZJ; Wang YH; Zhu HY; Miao KR; Liu P; Xu W; Li JY
    Cancer Sci; 2012 May; 103(5):875-81. PubMed ID: 22320315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients.
    Chauzeix J; Laforêt MP; Deveza M; Crowther L; Marcellaud E; Derouault P; Lia AS; Boyer F; Bargues N; Olombel G; Jaccard A; Feuillard J; Gachard N; Rizzo D
    Cancer Med; 2018 Jun; 7(6):2621-2628. PubMed ID: 29745034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.